MARV ENTPR LLC has a total of 17 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are AMYLEX PHARMACEUTICALS INC, INTERFERON SCIENCES INC and FELDER MITCHELL S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Felder Mitchell S | 17 |
#2 | Muse Danny W | 1 |
Publication | Filing date | Title |
---|---|---|
US2020291101A1 | Novel Treatment Method for Cockayne Syndrome | |
US2018303998A1 | Novel Treatment Method for Cockayne Syndrome | |
US2017049950A1 | Method for slowing the aging process | |
US2015056608A1 | Method for Treating Infectious Diseases Using Emissive Energy | |
US2015122733A1 | Method for the treatment of cancer | |
US2015079098A1 | Method of treating cancer | |
US2015030692A1 | Treatment for chronic pain syndromes | |
US2015027950A1 | Treatment for atherosclerosis | |
US2014251917A1 | Method for the treatment of multiple sclerosis |